A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers
NCT05354336
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
SHR6390(100mg)
DRUG:
SHR6390(125mg)
DRUG:
SHR6390(150mg)
Sponsor
The Affiliated Hospital of Qingdao University